1. Home
  2. T vs ABBV Comparison

T vs ABBV Comparison

Compare T & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AT&T Inc.

T

AT&T Inc.

HOLD

Current Price

$28.98

Market Cap

166.5B

ML Signal

HOLD

Logo AbbVie Inc.

ABBV

AbbVie Inc.

HOLD

Current Price

$231.39

Market Cap

400.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
T
ABBV
Founded
1983
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
166.5B
400.9B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
T
ABBV
Price
$28.98
$231.39
Analyst Decision
Buy
Buy
Analyst Count
20
19
Target Price
$30.39
$247.06
AVG Volume (30 Days)
33.5M
6.2M
Earning Date
01-01-0001
04-13-2026
Dividend Yield
3.83%
2.93%
EPS Growth
N/A
N/A
EPS
N/A
2.36
Revenue
N/A
$61,160,000,000.00
Revenue This Year
$4.32
$11.90
Revenue Next Year
$2.14
$8.24
P/E Ratio
$9.14
$100.14
Revenue Growth
N/A
8.57
52 Week Low
$22.95
$164.39
52 Week High
$29.79
$244.81

Technical Indicators

Market Signals
Indicator
T
ABBV
Relative Strength Index (RSI) 68.44 55.01
Support Level $27.14 $220.11
Resistance Level $29.38 $238.17
Average True Range (ATR) 0.61 5.39
MACD -0.03 0.66
Stochastic Oscillator 94.58 62.95

Price Performance

Historical Comparison
T
ABBV

About T AT&T Inc.

The wireless business contributes nearly 70% of AT&T's revenue. The company is the third-largest US wireless carrier, connecting 74 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 14% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential fixed-line services, about 12% of revenue, primarily consist of broadband internet access, serving 15 million customers. AT&T also has a sizable presence in Mexico, with 24 million customers, but this business only accounts for 3% of revenue. The company recently sold its 70% equity stake in satellite television provider DirecTV to its partner, private equity firm TPG.

About ABBV AbbVie Inc.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Share on Social Networks: